Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Durif

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Human Molecular Genetics|November 19, 2010
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European populationMohamad Saad, Suzanne Lesage, Aude Saint-Pierre, et al.
Annals of Neurology|August 26, 2025
Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker StudyMargherita Fabbri, Natalia Del Campo, Wassilios G Meissner, et al.
Brain : a Journal of Neurology|February 1, 2013
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorderPierre Burbaud, Anne-Hélène Clair, Nicolas Langbour, et al.
Journal of Parkinson'S Disease|July 24, 2022
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Neuroimage. Clinical|October 24, 2022
Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's diseaseLaila Khedher, Jean-Marie Bonny, Ana Marques, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2013
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphismStephan Klebe, Jean-Louis Golmard, Michael A Nalls, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2020
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective StudyMarie des Neiges Santin, Paul Voulleminot, Agathe Vrillon, et al.
Journal of Neurology|August 30, 2023
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric studyAna Marques, Elise Macias, Bruno Pereira, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Human Molecular Genetics|November 19, 2010
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European populationMohamad Saad, Suzanne Lesage, Aude Saint-Pierre, et al.
Annals of Neurology|August 26, 2025
Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker StudyMargherita Fabbri, Natalia Del Campo, Wassilios G Meissner, et al.
Brain : a Journal of Neurology|February 1, 2013
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorderPierre Burbaud, Anne-Hélène Clair, Nicolas Langbour, et al.
Journal of Parkinson'S Disease|July 24, 2022
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Neuroimage. Clinical|October 24, 2022
Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's diseaseLaila Khedher, Jean-Marie Bonny, Ana Marques, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2013
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphismStephan Klebe, Jean-Louis Golmard, Michael A Nalls, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2020
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective StudyMarie des Neiges Santin, Paul Voulleminot, Agathe Vrillon, et al.
Journal of Neurology|August 30, 2023
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric studyAna Marques, Elise Macias, Bruno Pereira, et al.
Pageof 13